155 related articles for article (PubMed ID: 26768827)
1. Feasibility and acceptability of delivering adolescent health interventions alongside HPV vaccination in Tanzania.
Watson-Jones D; Lees S; Mwanga J; Neke N; Changalucha J; Broutet N; Maduhu I; Kapiga S; Chandra-Mouli V; Bloem P; Ross DA
Health Policy Plan; 2016 Jul; 31(6):691-9. PubMed ID: 26768827
[TBL] [Abstract][Full Text] [Related]
2. Improving skills and institutional capacity to strengthen adolescent immunisation programmes and health systems in African countries through HPV vaccine introduction.
Dochez C; Burnett RJ; Mbassi SM; Were F; Musyoki A; Trovoada D; Mphahlele MJ
Papillomavirus Res; 2017 Dec; 4():66-71. PubMed ID: 29179872
[TBL] [Abstract][Full Text] [Related]
3. Tanzania's human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019.
Li AJ; Manzi F; Kyesi F; Makame Y; Mwengee W; Fleming M; Mkopi A; Mmbaga S; Lyimo D; Loharikar A
Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A38-A48. PubMed ID: 34229889
[TBL] [Abstract][Full Text] [Related]
4. The impact of a human papillomavirus (HPV) vaccination campaign on routine primary health service provision and health workers in Tanzania: a controlled before and after study.
Gallagher KE; Erio T; Baisley K; Lees S; Watson-Jones D
BMC Health Serv Res; 2018 Mar; 18(1):173. PubMed ID: 29530042
[TBL] [Abstract][Full Text] [Related]
5. National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation.
Mphuru A; Li AJ; Kyesi F; Mwengee W; Mazige F; Nshunju R; Shayo B; Giattas MR; Loharikar A; Lyimo D
Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A2-A9. PubMed ID: 33962839
[TBL] [Abstract][Full Text] [Related]
6. Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania.
Quentin W; Terris-Prestholt F; Changalucha J; Soteli S; Edmunds WJ; Hutubessy R; Ross DA; Kapiga S; Hayes R; Watson-Jones D
BMC Med; 2012 Nov; 10():137. PubMed ID: 23148516
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and sustainability of a school-based platform for integrated delivery of HPV vaccination with adolescent health services in Tanzania: qualitative insights from stakeholders.
Rosen JG; Guillaume D; Mlunde LB; Njiro BJ; Munishi C; Mlay D; Gerste A; Holroyd TA; Giattas MR; Morgan C; Kyesi F; Tinuga F; Ishengoma J; Sunguya BF; Limaye RJ
Health Policy Plan; 2023 Apr; 38(4):486-495. PubMed ID: 36779391
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of delivering HPV vaccine to girls aged 10 to 15 years in Uganda.
Mugisha E; LaMontagne DS; Katahoire AR; Murokora D; Kumakech E; Seruyange R; Tsu VD
Afr Health Sci; 2015 Mar; 15(1):33-41. PubMed ID: 25834528
[TBL] [Abstract][Full Text] [Related]
9. Promoting adolescent health through integrated human papillomavirus vaccination programs: The experience of Togo.
Engel D; Afeli ADJ; Morgan C; Zeck W; Ross DA; Vyankandondera J; Bloem P; Adjeoda KR
Vaccine; 2022 Mar; 40 Suppl 1():A100-A106. PubMed ID: 34844819
[TBL] [Abstract][Full Text] [Related]
10. School-based vaccination programmes: An evaluation of school immunisation delivery models in England in 2015/16.
Tiley K; Tessier E; White JM; Andrews N; Saliba V; Ramsay M; Edelstein M
Vaccine; 2020 Mar; 38(15):3149-3156. PubMed ID: 31980192
[TBL] [Abstract][Full Text] [Related]
11. Integration of other services with human papillomavirus vaccination; lessons from earlier in the life course highlight the need for new policy and implementation evidence.
Morgan C; Giattas MR; Holroyd T; Pfitzer A; Engel D; Sidibe A; Holloway M; Bloem P; Fields R; Shimp L; Kumar S
Vaccine; 2022 Mar; 40 Suppl 1():A94-A99. PubMed ID: 35105493
[TBL] [Abstract][Full Text] [Related]
12. Qualitative study of the feasibility of HPV vaccine delivery to young adolescent girls in Vietnam: evidence from a government-implemented demonstration program.
LaMontagne DS; Nghi NQ; Nga le T; Janmohamed A; Huyen DT; Hien NT; Tsu VD
BMC Public Health; 2014 Jun; 14():556. PubMed ID: 24898950
[TBL] [Abstract][Full Text] [Related]
13. Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: Stakeholders' perspectives.
Abdullahi LH; Hussey GD; Wiysonge CS; Kagina BM
S Afr Med J; 2020 May; 110(6):525-531. PubMed ID: 32880566
[TBL] [Abstract][Full Text] [Related]
14. Potential process improvements to increase coverage of human papillomavirus vaccine in schools - A focus on schools with low vaccine uptake.
Selvey LA; Roux F; Burns S
Vaccine; 2020 Mar; 38(14):2971-2977. PubMed ID: 32115296
[TBL] [Abstract][Full Text] [Related]
15. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
Watson M; Shaw D; Molchanoff L; McInnes C
Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
[TBL] [Abstract][Full Text] [Related]
16. Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries.
Kabakama S; Gallagher KE; Howard N; Mounier-Jack S; Burchett HE; Griffiths UK; Feletto M; LaMontagne DS; Watson-Jones D
BMC Public Health; 2016 Aug; 16(1):834. PubMed ID: 27543037
[TBL] [Abstract][Full Text] [Related]
17. Perceptions of human papillomavirus vaccination of adolescent schoolgirls in western Uganda and their implications for acceptability of HPV vaccination: a qualitative study.
Turiho AK; Okello ES; Muhwezi WW; Katahoire AR
BMC Res Notes; 2017 Aug; 10(1):431. PubMed ID: 28854964
[TBL] [Abstract][Full Text] [Related]
18. Community-based household assessment of human papillomavirus (HPV) vaccination coverage and acceptability - HPV vaccine demonstration program, Cambodia - 2017.
Garon J; Wuddhika IV; Sreenivasan N; Wannemuehler K; Vutthikol Y; Chhorvann C; Loharikar A
Vaccine; 2019 Feb; 37(9):1202-1208. PubMed ID: 30686637
[TBL] [Abstract][Full Text] [Related]
19. Policy makers' perspective on the provision of maternal health services via mobile health clinics in Tanzania-Findings from key informant interviews.
Neke NM; Gadau G; Wasem J
PLoS One; 2018; 13(9):e0203588. PubMed ID: 30192851
[TBL] [Abstract][Full Text] [Related]
20. The feasibility of universal HPV vaccination program in Shenzhen of China: a health policy analysis.
Chen R; Wong E
BMC Public Health; 2019 Jun; 19(1):781. PubMed ID: 31221112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
